Susan D. DeVore - 10 May 2023 Form 4 Insider Report for Elevance Health, Inc. (ELV)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
12 May 2023, 16:13:08 UTC
Prior SEC filing
31 May 2022
Next SEC filing
30 May 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Kathleen S. Kiefer, Attorney in fact

Key filing fact

Susan D. DeVore filed Form 4 for Elevance Health, Inc. (ELV) on 12 May 2023.

Key facts

  • This page summarizes Susan D. DeVore's Form 4 filing for Elevance Health, Inc. (ELV).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 12 May 2023, 16:13.

Change

  • Previous filing in this sequence was filed on 31 May 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ELV transaction

Common Stock

Award

Transaction value
$0
Shares
+457
Change %
+53%
Price
$0.000000
Shares after
1,313
Date
10 May 2023
Ownership
Direct
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program.

Footnote F2

The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .